Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
出版年份 2020 全文链接
标题
Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-23
DOI
10.1186/s12967-020-02295-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer
- (2018) Mikkel Rosendahl et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer
- (2017) J. Alejandro Rauh-Hain et al. JAMA Oncology
- Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV
- (2016) Beyhan Ataseven et al. GYNECOLOGIC ONCOLOGY
- Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer
- (2016) Amin P. Makar et al. ONCOLOGIST
- Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study
- (2015) Yulan Ren et al. BMC CANCER
- Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer
- (2015) Jing-Yi Chern et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients
- (2015) Seung-Hyuk Shim et al. GYNECOLOGIC ONCOLOGY
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer
- (2014) Marco Petrillo et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Quality indicators in ovarian cancer surgery: Report from the French Society of Gynecologic Oncology (Société Française d'Oncologie Gynécologique, SFOG)
- (2013) D. Querleu et al. ANNALS OF ONCOLOGY
- Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: Is there a case for thoracic cytoreduction?
- (2013) Tamar Perri et al. GYNECOLOGIC ONCOLOGY
- Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
- (2013) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
- (2012) Claes G. Tropé et al. EUROPEAN JOURNAL OF CANCER
- Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
- (2012) S. Mahner et al. EUROPEAN JOURNAL OF CANCER
- Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease
- (2012) Suk-Joon Chang et al. GYNECOLOGIC ONCOLOGY
- Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice
- (2012) Mathieu Luyckx et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Multi-Center Evaluation of Post-Operative Morbidity and Mortality after Optimal Cytoreductive Surgery for Advanced Ovarian Cancer
- (2012) Arash Rafii et al. PLoS One
- Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
- (2011) J. Alejandro Rauh-Hain et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical Risk Score Predicts Suboptimal Debulking or a Major Perioperative Complication in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- (2011) Caitlin Stashwick et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas
- (2010) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
- (2009) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma
- (2008) Sean C. Dowdy et al. GYNECOLOGIC ONCOLOGY
- Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
- (2007) William E. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now